Pharmacokinetics and tolerability of intravenous infusion of adenosine (SUNY4001) in healthy volunteers

British Journal of Clinical Pharmacology

Volumn 50, Issue 2, 2000, Pages 177-181

  Uematsu, Toshihiko ^a   Kozawa, Osamu ^a   Matsuno, Hiroyuki ^a   Niwa, Masayuki ^a   Yoshikoshi, Hirofumi ^b   Oh Uchi, Mikio ^b   Kohno, Ken Ichi ^a,c   Nagashima, Satoru ^a,c   Kanamaru, Mitsutaka ^c  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SUNTORY LTD   (Japan)

^c Shitoro Clinic   (Japan)

Author keywords

Adenosine; Healthy volunteer; Metabolite; Pharmacokinetics; Tolerability

Indexed keywords

ADENOSINE; HYPOXANTHINE; INOSINE; SUNY 4001; URIC ACID; XANTHINE;

ADULT; ARTICLE; ATRIOVENTRICULAR BLOCK; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG TOLERABILITY; DYSPNEA; HOT FLUSH; HUMAN; HUMAN EXPERIMENT; JAPAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; THORAX PAIN; URINALYSIS;

EID: 0033860940     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2000.00214.x     Document Type: Article

References (14)

1. 1 Albro PC, Gould KL, Westcott RJ, Hamilton GW, Ritchie JL, Williams DL. Noninvasive assessment of coronary stenosis by myocardial imaging during pharmacologic coronary vasodilation. III. Clinical trial. Am J Cardiol 1978; 42: 751-760.
2. 2 Klabunde RE. Dipyridamole inhibition of adenosine metabolism in human blood. Eur J Pharmacol 1983; 21; 21-26.
3. 3 Knabb RM, Gidday JM, Ely SW, Rubio R, Berne RM. Effects of dipyridamole on myocardial adenosine and active hyperemia. Am J Physiol 1984; 247: H804-H810.
4. 4 Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD. Effects of adenosine on human coronary arterial circulation. Circulation 1990; 82: 1595-1606.
5. 5 DiMarco JP, Miles W, Akhtar M, et al. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. Ann Intern Med 1990; 113: 104-110.
6. 6 Siffring PA, Gupta NC, Mohiuddin SM, et al. Myocardial uptake and clearance of T1-201 in healthy subjects: comparison of adenosine-induced hyperemia and exercise stress. Radiology 1989; 173: 769-774.
7. 7 Abreu A, Mahmarian JJ, Nishimura S, Boyce TM, Verani MS. Tolerance and safety of pharmacologic coronary vasodilation with adenosine in association with thallium-201 scintigraphy in patients with suspected coronary artery disease. J Am Coll Cardiol 1991; 18: 730-735.
8. 8 Blardi P, Laghi Pasini F, Urso R, et al. Pharmacokinetics of exogenous adenosine in man after infusion. Eur J Clin Pharmacol 1993; 44: 505-507.
9. 9 Yamane R, Nakamura T, Matsuura E, Ishige H, Fujimoto M. A simple and sensitive radioimmunoassay for adenosine. J Immunoassay 1991; 12: 501-519.
10. 10 Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profile of adenosine stress perfusion imaging: Results from the adenoscan multicenter trial registry. J Am Coll Cardiol 1994; 23: 384-389.
11. 11 Nishimura S, Mahmarian JJ, Boyce TM, Verani MS. Equivalence between adenosine and exercise thallium-201 myocardial tomography: a multicenter, prospective, crossover trial. J Am Coll Cardiol 1992; 20: 265-275.
12. 12 Bertlet BD, Hill JA. Adenosine: diagnostic and therapeutic uses in cardiovascular medicine. Chest 1993; 104: 1860-1871.
13. 13 Belhassen B, Pelleg G, Shoshani D, Laniado S. Atrial fibrillation induced by adenosine triphosphate. Am J Cardiol 1984; 53: 1405-1406.
14. 14 Belardinelli L, Isenberg G. Isolated atrial myocytes: adenosine and acetylcholine increase potassium conductance. Am J Physiol 1983; 244: H734-H737.